GLAXOSMITHKLINE US TRADING LIMITED
Company number 11566030 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2018-09-12
- Registered office
- C/O Bdo Llp, 5 Temple Square, Temple Street, Liverpool, L2 5RH
- Postcode
- L2 5RH
- Capital
- 100 USD
- Accounts category
- Full
Accounts
- Last made up to
- 2024-12-31
- Next due by
- 2026-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2025-09-29
- Next due by
- 2026-10-13
Nature of business (SIC)
- 46460 Wholesale of pharmaceutical goods
Officers 5 current · 11 resigned
Group structure
Controlled by GLAXO GROUP LIMITED — since 2018-09-12
From persons-with-significant-control filings on the public register.
Modern slavery statement
Registered a modern slavery statement for 2026 (period to 2025-12-31) as part of the GSK PLC group statement — 6 years on the registry.
Read the statement summary on the government modern slavery statement registry. Contains public sector information licensed under the Open Government Licence v3.0.
Contact details
- Website
- glaxosmithkline.org.uk
The class of 2018
32%
of the 339 companies in this sector incorporated in 2018 are still active today; 62% have since been dissolved.
A fact about the year, not a forecast for this company.